Fraunhofer IZI and BioNTech to collaborate in the future
13. May 2022 • Knowledge intensive service
The Mainz-based company BioNTech and the Fraunhofer IZI’s Molecular Drug Biochemistry and Therapy Development department, based in Halle (Saale), will collaborate in the field of biological assays in the future.
The Fraunhofer researchers will contribute their many years of expertise in establishing cellular and molecular biological analysis and model systems to the collaboration. In addition to cell-based assays, they will perform gene expression analyses as well as immunological and protein chemical methods for in vitro characterization.
University Hospital Leipzig partnered with Apple to hold its first workshop on spatial computing for neurosurgeons in November 2024. The course offered insights into and hands-on practice with this latest technology.
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.